Embecta (EMBC) Cash & Equivalents (2022 - 2026)
Embecta (EMBC) posted Cash & Equivalents of $184.9 million for Q1 2026, down 8.15% sequentially from $201.3 million in Q4 2025, and down 11.66% YoY from $209.3 million in Q1 2025.
Embecta (EMBC) Cash & Equivalents (2022 - 2026) Analysis & Trends
Embecta has reported Cash & Equivalents for 5 years, with the latest figure at $184.9 million in Q1 2026.
- Quarterly Cash & Equivalents fell 11.66% year-over-year to $184.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $184.9 million (down 11.66% YoY) and the FY2025 annual result came in at $225.5 million, down 15.7% from the prior year.
- Cash & Equivalents fell to $184.9 million in Q1 2026 per EMBC's latest filing, from $201.3 million in the prior quarter.
- Over five years, Cash & Equivalents peaked at $385.2 million in Q4 2022 and troughed at $184.9 million in Q1 2026.
- A 5-year average of $274.4 million and a median of $275.1 million in 2024 frame the typical range for Cash & Equivalents.
- The sharpest annual moves came in 2023 and 2025: Cash & Equivalents jumped 31.06% in 2023, then slumped 30.19% in 2025.
- Over 5 years, Cash & Equivalents stood at $385.2 million in 2022, then declined by 22.46% to $298.7 million in 2023, then retreated by 29.7% to $210.0 million in 2024, then slipped by 4.14% to $201.3 million in 2025, then retreated by 8.15% to $184.9 million in 2026.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $184.9 million, $201.3 million, and $225.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 2.76 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 708.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 1.36 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 1.47 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 2.33 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 435.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 403.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 138.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 2.15 Bn |
| 10 | Embecta | 305.26 Mn | 87.06 Mn | 153.30 Mn | 214.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 214.70 Mn |
| Mar 31, 2026 | 184.90 Mn |
| Dec 31, 2025 | 201.30 Mn |
| Sep 30, 2025 | 225.50 Mn |
| Jun 30, 2025 | 230.60 Mn |
| Mar 31, 2025 | 209.30 Mn |
| Dec 31, 2024 | 210.00 Mn |
| Sep 30, 2024 | 267.50 Mn |
| Jun 30, 2024 | 275.10 Mn |
| Mar 31, 2024 | 299.80 Mn |
| Dec 31, 2023 | 298.70 Mn |
| Sep 30, 2023 | 326.30 Mn |
| Jun 30, 2023 | 317.40 Mn |
| Mar 31, 2023 | 346.40 Mn |
| Dec 31, 2022 | 385.20 Mn |
| Sep 30, 2022 | 330.90 Mn |
| Jun 30, 2022 | 292.30 Mn |
| Mar 31, 2022 | 264.30 Mn |